AiCure

Europe

Report: Cancer survival in England improving using cancer staging data

Wednesday, August 27, 2014 01:17 PM

Cancer survival in England for breast, lung, prostate, colorectal and ovarian cancer continues to improve, according to new data published in a report from Public Health England’s National Cancer Intelligence Network (NCIN).

More... »


Cilag International acquires Covagen

Wednesday, August 27, 2014 01:13 PM

Cilag International, a Switzerland-based affiliate of Janssen Pharmaceutical, a division of Johnson & Johnson, has acquired Covagen, a privately held biopharmaceutical company specializing in the development of multi-specific protein therapeutics through the FynomAb technology platform.

More... »


Exco InTouch achieves quality milestone with ISO9001:2008 certification

Monday, August 25, 2014 09:00 AM

Exco InTouch, a U.K. provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, has been approved to ISO9001:2008 by Lloyd’s Register Quality Assurance (LRQA), a global provider of independent assessment services.

More... »

Medical Research Council finds flaws with U.K. molecular pathology landscape

Friday, August 22, 2014 11:56 AM

The Medical Research Council (MRC) has published a review of the U.K.’s capabilities in molecular pathology—the discipline that uses analysis of the molecules within tissue and body fluids to aid in a more accurate diagnosis and monitoring of disease. The review identifies three areas which, if not addressed, could inhibit the discovery, development and adoption of innovative diagnostic tests that will ultimately offer clinical, economic and research benefits.

More... »

Accovion designs new international structure for clinical operations

Tuesday, August 5, 2014 08:00 AM

Accovion, an independent, European CRO, has announced a new international structure for its clinical operations designed to facilitate the company's strategic plans for growth throughout Europe.

More... »

ibidi awarded with seal of quality

Monday, August 4, 2014 03:44 PM

The German Stifterverband, an association that promotes science and education in Germany, has awarded ibidi with their seal of quality for the company's ongoing and focused commitment to research and development.

More... »

U.K. genomics projects granted $505M

Friday, August 1, 2014 01:41 PM

Genomics England’s 100,000 Genomes Project has received a package of investment worth more than $505 million. The four year project focuses on new research to decode 100,000 human genomes—a patient’s personal DNA code.

More... »

Report: U.K. dementia diagnosis has increased 62% in seven years

Thursday, July 31, 2014 12:38 PM

According to Health and Social Care Information Center (HSCIC), provisional figures show 344,000 patients in the U.K. had a recorded diagnosis of dementia in 2013-2014. This is a rise from 319,000 in 2012-2013 and from 213,000 in 2006-2007, when the data was first collected.

More... »

Report: Generics increase to more than 75% of all 2013 prescriptions in England, Wales

Monday, July 28, 2014 03:04 PM

Usage of generic medicines in England and Wales increased to more than three-quarters of all NHS prescriptions in 2013, according to the latest figures supplied by the Health and Social Care Information Center (HSCIC).

More... »

ESMO concerned about impact of proposed E.U. data protection regulation on cancer research

Monday, July 28, 2014 03:01 PM

ESMO (the European Society of Medical Oncology) has expressed concern the proposed E.U. General Data Protection Regulation could make cancer research impossible and add a significant burden to both doctors and cancer patients.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs